About Adrian Stecyk
Adrian Stecyk is a chief executive officer and director at Myrtelle.
Adrian Stecyk first appears on SEC filings in 2024.
Experience
This experience comes from Adrian Stecyk's profile and from SEC filings. For roles taken from filings, the years are when the filings name Adrian Stecyk in the role, so the role may have started earlier or lasted longer.
Myrtelle Inc. Current
CEO (2021 – Present)
Director
2021 – Present · New York, NY
Develops gene therapies for people with neurological diseases.
AL
Aletheia Neuroenergetics LLC Current
Co-Founder
2019 – Present
GI
Griffin Securities, Inc. Current
Chairman & CEO
1997 – Present
AB
Agilis Biotherapeutics
Co-Founder
2013 – 2018
Key Colleagues at Startups
The people Adrian Stecyk works with at each company, as listed on that company's latest Form D.
Myrtelle Inc. · Form D, Jul 2, 2026
LP
Laurie Platek
Director
MM
Michael Muhonen
Co-Chief Medical Officer and director
DY
Debra Yu
Director
CB
Chrystyna Bedrij
Director
TB
Thomas Barton
Director